Literature DB >> 12660124

Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit.

M Thuong1, K Arvaniti, R Ruimy, P de la Salmonière, A Scanvic-Hameg, J C Lucet, B Régnier.   

Abstract

Because of a high prevalence of Pseudomonas aeruginosa infections, we conducted an epidemiological study to assess the need for systematic surveillance, as well as the value of applying barrier precautions toP. aeruginosa carriers. From July 1997 to February 1998, we conducted a prospective cohort study in an 18-bed medical intensive care unit (ICU), which is part of the infectious diseases department in a 1200-bed tertiary-care teaching hospital. Rectal and oropharyngeal swabs were obtained on admission and twice weekly. Acquired strains were genotypically characterized by pulsed-field gel electrophoresis (PFGE). A risk factor analysis for carriage, colonization and infection was performed. Among 269 eligible patients, 116 (43%) were P. aeruginosa carriers, with 46 (17%) detected on admission and 70 (26%) who acquired carriage during their stay in ICU. Among these 70 patients, 29 became colonized (N=13) or developed infection (N=16). Conversely, in the 121 patients who remained free of carriage, no colonization or infection were detected. Genotyping analysis using PFGE was performed for 81/85 (95%) acquired strains in 67 patients. The same genotype I was observed for 58/81 (70%) of these strains issued from 47 patients, and a distinct genotype II affected two other patients (three strains). The last 20 strains were not genetically related. In a multivariate model, mechanical ventilation was associated with the acquisition of P. aeruginosa carriage. Antibiotics ineffective against P. aeruginosa significantly increased the risk of colonization or infection in ICU. Although several recent studies concluded that endogenous sources account for the majority of P. aeruginosa colonizations or infections, we conclude that epidemiology may vary according to the ICU, and that cross-colonization (i.e., exogenous source) may occur and warrant reinforced barrier precautions.

Entities:  

Mesh:

Year:  2003        PMID: 12660124     DOI: 10.1053/jhin.2002.1370

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  24 in total

1.  High-Resolution Analysis by Whole-Genome Sequencing of an International Lineage (Sequence Type 111) of Pseudomonas aeruginosa Associated with Metallo-Carbapenemases in the United Kingdom.

Authors:  Jane F Turton; Laura Wright; Anthony Underwood; Adam A Witney; Yuen-Ting Chan; Ali Al-Shahib; Catherine Arnold; Michel Doumith; Bharat Patel; Timothy D Planche; Jonathan Green; Richard Holliman; Neil Woodford
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

2.  Tracking Pseudomonas aeruginosa transmissions due to environmental contamination after discharge in ICUs using mathematical models.

Authors:  Thi Mui Pham; Mirjam Kretzschmar; Xavier Bertrand; Martin Bootsma
Journal:  PLoS Comput Biol       Date:  2019-08-28       Impact factor: 4.475

3.  Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease.

Authors:  Guoxian Wei; Na Tian; Adriana C Valery; Yi Zhong; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Gastroenterol       Date:  2015-04-21       Impact factor: 10.864

4.  Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization.

Authors:  P Margreet G Filius; Inge C Gyssens; Irma M Kershof; Patty J E Roovers; Alewijn Ott; Arnold G Vulto; Henri A Verbrugh; Hubert P Endtz
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 5.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

6.  Faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae among paediatric units in different hospitals in the south of France.

Authors:  A Boutet-Dubois; A Pantel; M-F Prère; O Bellon; N Brieu-Roche; E Lecaillon; A Le Coustumier; A Davin-Regli; L Villeneuve; N Bouziges; E Gleize; R Lamarca; C Dunyach-Remy; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-15       Impact factor: 3.267

7.  Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients.

Authors:  E Velasco; M Soares; R Byington; C A S Martins; M Schirmer; L M C Dias; V M S Gonçalves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-28       Impact factor: 3.267

8.  In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.

Authors:  Shigeharu Oie; Yumi Fukui; Masaya Yamamoto; Yuki Masuda; Akira Kamiya
Journal:  BMC Infect Dis       Date:  2009-08-10       Impact factor: 3.090

Review 9.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Red death in Caenorhabditis elegans caused by Pseudomonas aeruginosa PAO1.

Authors:  Alexander Zaborin; Kathleen Romanowski; Svetlana Gerdes; Christopher Holbrook; Francois Lepine; Jason Long; Valeriy Poroyko; Stephen P Diggle; Andreas Wilke; Karima Righetti; Irina Morozova; Trissa Babrowski; Donald C Liu; Olga Zaborina; John C Alverdy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.